{{Drugbox
| Watchedfields = changed
| verifiedrevid = 459591021
| IUPAC_name = 3-(3-chloro-10,11-dihydro-5''H''-dibenzo[''b'',''f'']azepin-5-yl)-''N'',''N''-dimethylpropan-1-amine
| image = Clomipramine2DACS.svg
| alt = Skeletal formula of clomipramine
| width = 200px
| image2 = Clomipramine-3D-balls.png
| alt2 = Ball-and-stick model of the clomipramine molecule
| width2 = 200px
<!--Clinical data-->
| tradename = Anafranil、Clomicalm，及其他
| Drugs.com = {{drugs.com|monograph|clomipramine-hydrochloride}}
| licence_US = Clomipramine
| MedlinePlus = a697002
| pregnancy_AU = C
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[口服给药|口服]]、[[靜脈注射|靜脈注射]]<ref name="Maudsley">{{cite book | isbn = 978-0-47-097948-8 | title = Maudsley Prescribing Guidelines in Psychiatry | edition = 11th |author1=Taylor, D |author2=Paton, C |author3=Shitij, K | date = 2012 | publisher = Wiley-Blackwell | location = West Sussex }}</ref>
<!--Pharmacokinetic data-->
| bioavailability = ~50%<ref name="LemkeWilliams2012" />
| protein_bound = 96–98%<ref name="LemkeWilliams2012" />
| metabolism = [[肝臟|肝臟]]（[[CYP2D6|CYP2D6]]）<ref name="LemkeWilliams2012" />
| metabolites = {{tsl|en|Desmethylclomipramine||Desmethylclomipramine}}<ref name="LemkeWilliams2012" />
| elimination_half-life = {{abbr|CMI|Clomipramine}}: 19–37 hours<ref name="LemkeWilliams2012">{{cite book|author1=Thomas L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA604|date=24 January 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-60913-345-0|pages=604–605|deadurl=no|archiveurl=https://web.archive.org/web/20170908174253/https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA604|archivedate=8 September 2017|df=}}</ref><br />{{abbr|DCMI|Desmethylclomipramine}}: 54–77 hours<ref name="LemkeWilliams2012" />
| excretion = [[腎|腎]]（51–60%）<ref name="LemkeWilliams2012" /><br />[[糞便|糞便]]（24–32%）<ref name="LemkeWilliams2012" />
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 303-49-1
| ATC_prefix = N06
| ATC_suffix = AA04
| PubChem = 2801
| IUPHAR_ligand = 2398
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01242
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2699
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = NUV44L116D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07727
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 47780
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 415
| synonyms = Clomimipramine; 3-Chloroimipramine; G-34586<ref name="Elks2014" />
<!--Chemical data-->
| C=19 | H=23 | Cl=1 | N=2
| molecular_weight = 314.857 g/mol
| SMILES = ClC1=CC(N(CCCN(C)C)C2=C(CC3)C=CC=C2)=C3C=C1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GDLIGKIOYRNHDA-UHFFFAOYSA-N
}}
{{medical}}
<!-- Definition and medical uses -->
'''氯米帕明'''（Clomipramine），常見商品名Anafranil，為一種[[三环类抗抑郁药|三环类抗抑郁药]]（TCA）<ref name=AHFS2015>{{cite web|title=Clomipramine Hydrochloride|url=https://www.drugs.com/monograph/clomipramine-hydrochloride.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208153943/http://www.drugs.com/monograph/clomipramine-hydrochloride.html|archivedate=2015-12-08|df=}}</ref>。本品可用於治療[[强迫症|强迫症]]、[[恐慌症|恐慌症]]、[[重性抑郁障碍|重性抑郁障碍]]，以及[[慢性疼痛|慢性疼痛]]等等<ref name=AHFS2015/>。65歲以上年長者用藥會降低[[自殺|自殺]]風險<ref name=AHFS2015/>。本品為口服藥<ref name=AHFS2015/>。

<!-- Side effects and mechanism -->
副作用包含口乾、便秘、食慾下降、昏睡、性功能障礙，以及排尿困難等等<ref name=AHFS2015/>。嚴重副作用則包含[[癲癇|癲癇]]、[[狂躁|狂躁]]，以及肝臟問題，25歲以下年輕人用藥可能會增加[[自殺|自殺]]風險<ref name=AHFS2015/>。驟然停藥可能會出現戒斷症，包含頭痛、盜汗，以及[[頭暈|頭暈]]等等<ref name=AHFS2015/>。妊娠期間用藥的安全性迄今未明<ref name=AHFS2015/>。其作用機轉上不清楚，可能與增加血液中[[血清素|血清素]]含量有關<ref name=AHFS2015/>

<!-- History, society and culture -->
氯米帕明最早由瑞士製藥公司[[诺华公司|诺华公司]]於1964年發現<ref name=Zohar2012/>，本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。本品屬[[通用名药物|通用名药物]]<ref name=AHFS2015/>。2014年，其每日劑量於[[发展中国家|发展中国家]]的批發價約介於0.11至0.21之間<ref>{{cite web|title=Clomipramine|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=195&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=3 December 2015}}</ref>。在美國，本品每日正常劑量約為1.20美金<ref name=AHFS2015/>。本品由{{tsl|en|imipramine|伊米帕明}}合成而得<ref name=Zohar2012/>。
{{TOC limit|3}}

==參考文獻==
{{Reflist}}

{{Antidepressants}}
{{Anxiolytics}}
{{OCD pharmacotherapies}}
{{Navboxes
| title = [[药物效应动力学|Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Adrenergic receptor modulators}}
{{Dopamine receptor modulators}}
{{Histamine receptor modulators}}
{{Ion channel modulators}}
{{Monoamine reuptake inhibitors}}
{{Muscarinic acetylcholine receptor modulators}}
{{Serotonin receptor modulators}}
{{Sigma receptor modulators}}
}}
{{Tricyclics}}

[[Category:胺|Category:胺]]
[[Category:抗组胺药物|Category:抗组胺药物]]
[[Category:氯代芳烴|Category:氯代芳烴]]
[[Category:二苯并氮䓬|Category:二苯并氮䓬]]
[[Category:多巴胺拮抗药|Category:多巴胺拮抗药]]
[[Category:蕈毒碱性受体拮抗剂|Category:蕈毒碱性受体拮抗剂]]
[[Category:血清素拮抗剂|Category:血清素拮抗剂]]
[[Category:血清素-去甲肾上腺素重摄取抑制剂|Category:血清素-去甲肾上腺素重摄取抑制剂]]
[[Category:Tricyclic_antidepressants|Category:Tricyclic antidepressants]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]